Pfizer (PFE) Cash from Discontinued Operations (2010 - 2022)

Pfizer (PFE) has 9 years of Cash from Discontinued Operations data on file, last reported at 5000000.0 in Q3 2022.

• Cash from Discontinued Operations for Q3 2022 came in at 5000000.0, down 129.41% year-over-year; the trailing twelve-month figure through Oct 2022 was 332000000.0 (down 115.84% YoY), and the FY2021 annual result was 343000000.0, down 108.88% from the prior year.
• Cash from Discontinued Operations grew to 5000000.0 in Q3 2022 per PFE's latest filing, from 327000000.0 in the prior quarter.
• Over five years, Cash from Discontinued Operations peaked at 2414000000.0 in Q3 2020 and troughed at 327000000.0 in Q4 2021.
• A 3-year average of 564428571.43 and a median of 17000000.0 in 2021 frame the typical range for Cash from Discontinued Operations.
• The sharpest annual moves came in 2021 and 2022: Cash from Discontinued Operations tumbled 98.07% in 2021, then slumped 129.41% in 2022.
• A 3-year view of Cash from Discontinued Operations shows it stood at 2414000000.0 in 2020, then slumped by 113.55% to 327000000.0 in 2021, then jumped by 98.47% to 5000000.0 in 2022.
• Business Quant data shows PFE's Cash from Discontinued Operations at 5000000.0 in Q3 2022, 327000000.0 in Q4 2021, and 17000000.0 in Q3 2021.